Sarepta Therapeutics Announces Third Quarter 2019 Financial Results and Recent Corporate Developments

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. APGE
5. MU
6. GOOGL
7. DFTX
8. KR
9. MSTR
10. HOOD

Go back to Sarepta Therapeutics Announces Third Quarter 2019 Financial Results and Recent Corporate Developments

Sarepta Therapeutics (SRPT) Tops Q3 EPS by 21c

November 7, 2019 5:09 PM EST

Sarepta Therapeutics (NASDAQ: SRPT) reported Q3 EPS of ($1.14), $0.21 better than the analyst estimate of ($1.35). Revenue for the quarter came in at $99 million versus the consensus estimate of $98.34 million.

For earnings history and earnings-related data on Sarepta Therapeutics (SRPT) click here.

... More